https://akiramtherapeutics.se/akiram-therapeutics-announces-agreement-with-leading-university-hospital-on-177lu-akir001-manufacturing-for-cancer-therapy/2024-10-01T09:45:52+00:00https://akiramtherapeutics.se/akiram-therapeutics-strengthens-board-with-drug-development-expertise/2024-05-30T11:08:48+00:00https://akiramtherapeutics.se/akiram-therapeutics-pioneering-cancer-research-backed-by-sek-6-million-from-the-erling-persson-foundation/2024-05-30T11:10:25+00:00https://akiramtherapeutics.se/akiram-therapeutics-to-present-promising-data-on-the-therapeutic-potential-of-its-drug-candidate-at-eanm-congress/2024-05-30T11:11:27+00:00https://akiramtherapeutics.se/ddd-exit-financed-with-68-msek-to-develop-novel-cancer-therapy/2024-05-30T11:12:04+00:00https://akiramtherapeutics.se/akiram-therapeutics-raises-sek-68-million-for-clinical-development-of-a-drug-candidate-for-rare-thyroid-cancers/2024-05-30T11:12:58+00:00https://akiramtherapeutics.se/latest-ddd-exit-radioactive-antibody-for-treatment-of-aggressive-cancer/2024-05-30T12:56:09+00:00https://akiramtherapeutics.se/she-is-creating-brilliant-chances-for-cancer-patients/2024-05-30T13:05:18+00:00https://akiramtherapeutics.se/new-research-advances-on-akir001-to-be-presented-at-eanm-congress-2024/2024-10-21T13:22:25+00:00https://akiramtherapeutics.se/akiram-therapeutics-drug-candidate-akir001-cleared-to-start-phase-1-clinical-trial/2024-10-22T06:48:56+00:00https://akiramtherapeutics.se/leading-the-future-of-radioimmunotherapy-for-cancer-treatment/2024-12-09T08:53:49+00:00https://akiramtherapeutics.se/akiram-therapeutics-initiates-eurostars-funded-collaboration-to-develop-next-generation-targeted-alpha-therapeutics/2025-04-03T13:41:19+00:00https://akiramtherapeutics.se/first-patient-enrolled-in-phase-1-clinical-trial-of-akirams-cancer-drug-candidate-akir001/2025-04-30T06:29:15+00:00https://akiramtherapeutics.se/clinical-phase-i-clinical-trial-with-akir001-progresses-to-next-step-following-completion-of-first-cohort/2025-08-25T07:45:19+00:00https://akiramtherapeutics.se/a-pioneer-in-targeted-radiotherapy-marika-nestor-featured-in-onkologi-i-sverige/2025-11-11T07:33:10+00:00https://akiramtherapeutics.se/akiram-therapeutics-research-selected-as-top-rated-oral-presentations-at-eanm-2025/2025-11-18T14:45:54+00:00https://akiramtherapeutics.se/akir001-publication-in-the-journal-of-nuclear-medicine-supports-ongoing-clinical-development/2025-12-03T08:13:10+00:00https://akiramtherapeutics.se/akiram-therapeutics-cohort-2a-completed-and-cohort-2b-cleared-to-start-in-phase-i-trial-of-akir001/2025-12-16T08:07:12+00:00https://akiramtherapeutics.se/akir001-study-selected-as-overall-featured-article-in-the-journal-of-nuclear-medicine/2026-02-15T09:38:30+00:00https://akiramtherapeutics.se/marika-nestor-featured-in-ssfs-om-vetenskap-podcast/2026-04-30T13:42:53+00:00